Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol

  • Authors:
    • Kun Guo
    • Qingyong Ma
    • Liancai Wang
    • Hengtong Hu
    • Junhui Li
    • Dong Zhang
    • Min Zhang
  • View Affiliations

  • Published online on: October 1, 2009     https://doi.org/10.3892/or_00000505
  • Pages: 825-830
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Active migration and invasion by cancer cells are a prerequisite for the development of metastases. Recent studies have shown that neurotransmitters are involved in the regulation of cancer cell invasion via β-adrenoceptors (β-ARs). However, little is known regarding the effect of neurotransmitters on pancreatic cancer cells. The aim of our study was to examine the regulative effect of norepinephrine (NE), which belongs to the group of classical neurotransmitters, on the invasiveness of pancreatic cancer cells and the therapeutic effect of the β-blocker, propranolol, on them. The human pancreatic cancer cell lines, Miapaca-2 and Bxpc-3, were selected for this study, and in both cell lines, β1-AR and β2-AR expression was determined by RT-PCR and Western blotting. The invasiveness of pancreatic cancer cells was examined using the Matrigel invasion assay. The concentrations of MMP-2, MMP-9, and VEGF in the culture medium and in the cancer cells were examined by ELISA and RT-PCR, respectively. We observed that NE promoted the invasiveness of Miapaca-2 cells in a concentration-dependent manner, and NE increased the expression of MMP-2, MMP-9, and VEGF. However, these effects could be inhibited by the β-blocker, propranolol. In conclusion, the development of metastases is not only genetically determined, but is also influenced by NE, which is one of the signal substances present in the tumor environment. This study also provides experimental evidence for the use of β-blockers in the chemoprevention of pancreatic cancer metastasis.

Related Articles

Journal Cover

October 2009
Volume 22 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D and Zhang M: Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 22: 825-830, 2009
APA
Guo, K., Ma, Q., Wang, L., Hu, H., Li, J., Zhang, D., & Zhang, M. (2009). Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncology Reports, 22, 825-830. https://doi.org/10.3892/or_00000505
MLA
Guo, K., Ma, Q., Wang, L., Hu, H., Li, J., Zhang, D., Zhang, M."Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol". Oncology Reports 22.4 (2009): 825-830.
Chicago
Guo, K., Ma, Q., Wang, L., Hu, H., Li, J., Zhang, D., Zhang, M."Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol". Oncology Reports 22, no. 4 (2009): 825-830. https://doi.org/10.3892/or_00000505